BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

327 related articles for article (PubMed ID: 18369304)

  • 1. Cervical screening and general physical examination behaviors of women exposed in utero to diethylstilbestrol.
    Camp EA; Coker AL; Troisi R; Robboy SJ; Noller KL; Goodman KJ; Titus-Ernstoff LT; Hatch EE; Herbst AL; Kaufman RH; Adam E
    J Low Genit Tract Dis; 2008 Apr; 12(2):111-7. PubMed ID: 18369304
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prenatal diethylstilbestrol (DES) exposure. Recommendations of the Diethylstilbestrol-Adenosis (DESAD) Project for the identification and management of exposed individuals.
    Clin Pediatr (Phila); 1983 Feb; 22(2):139-43. PubMed ID: 6822019
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Factors associated with a lack of pap smear utilization in women exposed in utero to diethylstilbestrol.
    Camp EA; Prehn AW; Shen J; Herbst AL; Strohsnitter WC; Hobday CD; Robboy SJ; Adam E
    J Womens Health (Larchmt); 2015 Apr; 24(4):308-15. PubMed ID: 25768943
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of DES-associated clear-cell carcinoma: the importance of regular screening.
    Anderson B; Watring WG; Edinger DD; Small EC; Netland AT; Safaii H
    Obstet Gynecol; 1979 Mar; 53(3):293-9. PubMed ID: 424100
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management of the adolescent girl exposed in utero to DES.
    Gerbie MV
    Pediatr Ann; 1981 Dec; 10(12):23-6. PubMed ID: 7335401
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Breast cancer screening in women exposed in utero to diethylstilbestrol.
    Camp EA; Coker AL; Robboy SJ; Noller KL; Goodman KJ; Titus-Ernstoff LT; Hatch EE; Herbst AL; Troisi R; Kaufman RH; Adam E
    J Womens Health (Larchmt); 2009 Apr; 18(4):547-52. PubMed ID: 19361323
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Colposcopic and pathologic features in two cases of DES-related vaginal clear-cell adenocarcinoma.
    Blythe JG; Michael H; Hodel KA
    J Reprod Med; 1983 Feb; 28(2):137-46. PubMed ID: 6834354
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diethylstilbestrol exposure and the risk of clear cell cervical and vaginal adenocarcinoma.
    Edelman DA
    Int J Fertil; 1989; 34(4):251-5. PubMed ID: 2570761
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The significance of adenosis and clear-cell adenocarcinoma of the genital tract in young females.
    Herbst AL; Scully RE; Robboy SJ
    J Reprod Med; 1975 Jul; 15(1):5-11. PubMed ID: 1151941
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preeclampsia risk in women exposed in utero to diethylstilbestrol.
    Troisi R; Titus-Ernstoff L; Hyer M; Hatch EE; Robboy SJ; Strohsnitter W; Palmer JR; Øglaend B; Adam E; Kaufman R; Herbst AL; Hoover RN
    Obstet Gynecol; 2007 Jul; 110(1):113-20. PubMed ID: 17601905
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cervical and vaginal cancer detection at a regional diethylstilbestrol (DES) screening clinic.
    Piver MS; Lele SB; Baker TR; Sandecki A
    Cancer Detect Prev; 1988; 11(3-6):197-202. PubMed ID: 3390844
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diethylstilbestrol exposure in utero: review of literature.
    Glaze GM
    J Am Osteopath Assoc; 1984 Feb; 83(6):435-8. PubMed ID: 6368486
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In utero diethylstilbestrol exposure: structural and epithelial abnormalities.
    Noller KL
    Cervix Low Female Genital Tract; 1983; 1(2):75-82. PubMed ID: 12266371
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mammography screening behaviors of women exposed prenatally to diethylstilbestrol.
    Camp EA; Robboy SJ; Hatch EE; Titus-Ernstoff LT; Herbst AL; Strohsnitter W; Kaufman RH; Adam E
    J Womens Health (Larchmt); 2012 Feb; 21(2):209-14. PubMed ID: 22150213
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-grade cervical abnormalities and screening intervals in New South Wales, Australia.
    Schindeler S; Morrell S; Zuo Y; Baker D
    J Med Screen; 2008; 15(1):36-43. PubMed ID: 18416954
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The current status of the DES-exposed population.
    Herbst AL
    Obstet Gynecol Annu; 1981; 10():267-78. PubMed ID: 7024873
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prenatal diethylstilbestrol exposure and risk of breast cancer.
    Palmer JR; Wise LA; Hatch EE; Troisi R; Titus-Ernstoff L; Strohsnitter W; Kaufman R; Herbst AL; Noller KL; Hyer M; Hoover RN
    Cancer Epidemiol Biomarkers Prev; 2006 Aug; 15(8):1509-14. PubMed ID: 16896041
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytologic examination to detect clear cell adenocarcinoma of the vagina or cervix.
    Hanselaar AG; Boss EA; Massuger LF; Bernheim JL
    Gynecol Oncol; 1999 Dec; 75(3):338-44. PubMed ID: 10600286
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Menstrual and reproductive characteristics of women whose mothers were exposed in utero to diethylstilbestrol (DES).
    Titus-Ernstoff L; Troisi R; Hatch EE; Wise LA; Palmer J; Hyer M; Kaufman R; Adam E; Strohsnitter W; Noller K; Herbst AL; Gibson-Chambers J; Hartge P; Hoover RN
    Int J Epidemiol; 2006 Aug; 35(4):862-8. PubMed ID: 16723367
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In utero exposure to diethylstilbestrol (DES) does not increase genomic instability in normal or neoplastic breast epithelium.
    Larson PS; Ungarelli RA; de Las Morenas A; Cupples LA; Rowlings K; Palmer JR; Rosenberg CL
    Cancer; 2006 Nov; 107(9):2122-6. PubMed ID: 16998936
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.